PR inside: RMTG Expands Peptide Education Platform With ISSCA Peptide Certification ...
(PR-inside.com) The upgraded program complements Cellgenic's expanding peptide training product portfolio and is intended as a current example of RMTG's education-to-product operating model.
MIAMI, FL / ACCESS Newswire / October 1, 2026 / Oct 1, 2026, Regenerative Medical Technology Group Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the launch of Peptide Certification 2.0 through its International Society for Stem Cell Applications (ISSCA) division, an expansion of the organization's peptide-medicine education and certification program.
The upgraded program expands ISSCA's peptide-medicine curriculum with updated educational modules, practical physician resources, and ..
https://reports.pr-inside.com/rmtg-expa ... 229277.htm
Copyright PR-Inside.com 2026
